Bayer’s Roundup Challenge: Avoid More ‘Nuclear’ Jury Awards
- Two more herbicide-cancer trials loom in Missouri, California
- Legal analyst says company needs to re-tool its ‘story lines’
Photographer: Jean Francois Monier/AFP via Getty Images
This article is for subscribers only.
As Bayer AG girds for two more trials over its Roundup weed killer, lawyers for consumers are angling to build on their first three courtroom victories that resulted in damages awards totaling $191 million.
The question for Bayer is, what can it do differently this time?
The German drug and chemical giant, which acquired Roundup maker Monsanto Co. in 2018, is trying to reverse the momentum of a litigation storm that has generated tens of thousands of cases alleging exposure to the herbicide causes cancer.